Risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis: Interim report of a phase II trial

R. L. Comenzo; P. Zhou; L. Reich; S. Costello; A. Quinn; S. Fircanis; L. Drake; C. Hedvat; J. Teruya-Feldstein; D. A. Filippa; M. Fleisher

Risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis: Interim report of a phase II trial

R. L. Comenzo, P. Zhou, L. Reich, S. Costello, A. Quinn, S. Fircanis, L. Drake, C. Hedvat, J. Teruya-Feldstein, D. A. Filippa, M. Fleisher

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Original language	English
Title of host publication	Amyloid and Amyloidosis
Publisher	CRC Press
Pages	112-114
Number of pages	3
ISBN (Electronic)	9781420037494
ISBN (Print)	0849335345, 9780849335341
State	Published - 1 Jan 2004
Externally published	Yes

Cite this

Comenzo, R. L., Zhou, P., Reich, L., Costello, S., Quinn, A., Fircanis, S., Drake, L., Hedvat, C., Teruya-Feldstein, J., Filippa, D. A., & Fleisher, M. (2004). Risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis: Interim report of a phase II trial. In Amyloid and Amyloidosis (pp. 112-114). CRC Press.

@inbook{02b36f3974cf4adea1ebae1a7a963cf3,

title = "Risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis: Interim report of a phase II trial",

author = "Comenzo, {R. L.} and P. Zhou and L. Reich and S. Costello and A. Quinn and S. Fircanis and L. Drake and C. Hedvat and J. Teruya-Feldstein and Filippa, {D. A.} and M. Fleisher",

year = "2004",

month = jan,

day = "1",

language = "English",

isbn = "0849335345",

pages = "112--114",

booktitle = "Amyloid and Amyloidosis",

publisher = "CRC Press",

}

Comenzo, RL, Zhou, P, Reich, L, Costello, S, Quinn, A, Fircanis, S, Drake, L, Hedvat, C, Teruya-Feldstein, J, Filippa, DA & Fleisher, M 2004, Risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis: Interim report of a phase II trial. in Amyloid and Amyloidosis. CRC Press, pp. 112-114.

Risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis: Interim report of a phase II trial. / Comenzo, R. L.; Zhou, P.; Reich, L. et al.
Amyloid and Amyloidosis. CRC Press, 2004. p. 112-114.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

TY - CHAP

T1 - Risk-adapted intravenous melphalan with adjuvant thalidomide and dexamethasone for newly diagnosed untreated patients with systemic AL amyloidosis

T2 - Interim report of a phase II trial

AU - Comenzo, R. L.

AU - Zhou, P.

AU - Reich, L.

AU - Costello, S.

AU - Quinn, A.

AU - Fircanis, S.

AU - Drake, L.

AU - Hedvat, C.

AU - Teruya-Feldstein, J.

AU - Filippa, D. A.

AU - Fleisher, M.

PY - 2004/1/1

Y1 - 2004/1/1

UR - http://www.scopus.com/inward/record.url?scp=85057689971&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85057689971

SN - 0849335345

SN - 9780849335341

SP - 112

EP - 114

BT - Amyloid and Amyloidosis

PB - CRC Press

ER -